» Articles » PMID: 9741859

Bayesian Decision Procedures Based on Logistic Regression Models for Dose-finding Studies

Overview
Journal J Biopharm Stat
Date 1998 Sep 19
PMID 9741859
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Early-phase clinical trials, conducted to determine the appropriate dose of an experimental drug to take forward to later trials, are considered. The objective is to find the dose associated with some low probability of an adverse event. A Bayesian model is presented, and a decision-theoretic procedure for finding the optimal doses for each of a series of cohorts of subjects is derived. The procedure is flexible and can easily be conducted using standard statistical software. The results of simulations investigating the properties of the procedure are presented.

Citing Articles

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs.

Ollier A, Mozgunov P Stat Med. 2025; 44(3-4):e10337.

PMID: 39853785 PMC: 11758501. DOI: 10.1002/sim.10337.


Dose finding studies for therapies with late-onset toxicities: A comparison study of designs.

Barnett H, Boix O, Kontos D, Jaki T Stat Med. 2022; 41(30):5767-5788.

PMID: 36250912 PMC: 10092569. DOI: 10.1002/sim.9593.


Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic.

Ewings S, Saunders G, Jaki T, Mozgunov P BMC Med Res Methodol. 2022; 22(1):25.

PMID: 35057758 PMC: 8771176. DOI: 10.1186/s12874-022-01512-0.


A dose-finding design for dual-agent trials with patient-specific doses for one agent with application to an opiate detoxification trial.

Mozgunov P, Cro S, Lingford-Hughes A, Paterson L, Jaki T Pharm Stat. 2021; 21(2):476-495.

PMID: 34891221 PMC: 7612599. DOI: 10.1002/pst.2181.


Bridging across patient subgroups in phase I oncology trials that incorporate animal data.

Zheng H, Hampson L, Jaki T Stat Methods Med Res. 2021; 30(4):1057-1071.

PMID: 33501882 PMC: 8129464. DOI: 10.1177/0962280220986580.